in phase i of the nhlbi trial of thrombolysis in myocardial infarction ( timi ) , 290 patients admitted within 7 hr after onset of acute infarction were randomly assigned to intravenous treatment with either streptokinase ( sk ) or recombinant tissue-type plasminogen activator ( rt-pa ) .
C0027051
myocardial infarction
C0021308
infarction